Abstract
The genus Mallotus is a large genus of trees/shrubs distributed chiefly in the tropical and subtropical regions of the Old World with around 20 species in India [1] . The genus Mallotus is represented by five species in Maharashtra, and Mallotus philippinensis (Lam.) Muell.Arg. (Euphorbiaceae) is a branched tree distributed throughout the state [2] . A red dye called Kamala is secreted on the surface of the fruits and is used medicinally as well as commercially as a dye. It has a purgative property and is also used in the external applications for parasitic infections of the skin. It also has a lithontriptic property that dissolves or destroys stones in the kidneys and it is styptic (antihemorrhagic agent). Earlier work on the chemical analysis of different parts of this tree has revealed the occurrence of several triterpenes [3, 4] , flavonoids [5] [6] [7] [8] , and dimeric chalcone derivatives [9, 10] . In our earlier work, from the acetone extract of whole uncrushed fruits of M. philippinensis, we isolated chalcones, including one new dimeric chalcone, kamalachalcone E, which was shown to have antifungal activity against the human pathogens Candida albicans, Candida glabrata, and Cryptococcus neoformans [11] . In the continuation of this work, we have examined the methanol extract of the crushed fruits of M. philippinensis to isolate 13 compounds (1-13) and evaluated them for antimycobacterium activity against Mycobacterium tuberculosis H37Ra. Fig. S3 , Supporting Information) spectra showed the presence of eight methyls, nine methylenes, seven methines, and six quaternary carbons, including two carbonyl groups at δ C 209.0 and 209.6. This data suggests that compound 1 was a tetracyclic triterpenoid belonging to the class lanostanol. The complete structure was elucidated by 2D NMR. A proton at δ H 2.59 (H-12) showed an HMBC correlation with the carbonyl carbon at δ C 209.6 (C-11), while a proton at δ H 1.26 (H-5) showed an HMBC correlation with the carbonyl carbon at δ C 209.0 (C-7). The key HMBC correlations are shown in Fig. S4 (Fig. S4, Supporting Information) . Thus, 1 was identified as 7,11-diketo-lanost-3β-ol. It has been prepared synthetically and reported earlier [12] . To the best of our knowledge, this is the first report of the isolation of compound 1 as a new natural product. Compounds 2-13 were identified as lanosta-8-ene-3β-ol (2, as acetate) [13] , pregnenolone (3, as acetate) [14] , trans-chalcone (4), kamalachalcone E (5) [11] , oleanolic acid (6) [15] , gallic acid (7) [16] , kaempferol (8) [17] , myricetin (9) [18], 3.3.2 1-(5,7-dihydroxy-2,2,6-trimethyl-2H-1-benzopyran-8-yl)-3-phenyl-2-propen-1-one (10) [11] , 4′-hydroxyisorottlerin (11) [10] , rottlerin (12) [11] , and shikimic acid (13) [19] (l " Fig. 1 ) by comparison with the literature NMR data and were confirmed by the LC-E-SI-MS. An attempt has been made to define the configuration of compound 11 by comparing it with structurally similar flavanone derivatives. Compound 11 was determined to have a negative specific rotation, [α] D 26 − 12.11 (c 0.6, chloroform). Literature analysis suggests that the negative specific rotation was consistent with the α orientation of the group at position 2 [20] [21] [22] . This allowed for the determination of the α orientation of the group at position 2 in compound 11. Compounds 1-13 were evaluated for their antimycobacterium activity against M. tuberculosis H37Ra. Compounds 11 and 12 exhibited antimycobaterium activity with IC 50 values of 0.89 ± 0.33 µg/mL (MIC 2.06 ± 0.41 µg/mL) and 7.59 ± 0.42 µg/mL (MIC 11.56 ± 0.35 µg/mL), respectively, as compared to the positive control rifampicin.
Materials and Methods

!
General experimental procedures
1 H and 13 C NMR spectra were recorded on a Bruker Avance III Ultra Shield NMR ( 1 H operating frequency: 400 MHz) instrument. LC-ESI-MS was recorded with the Waters Acquity LC-MS instru-ment. Optical rotations were measured with a JASCO P-1020 polarimeter. The Spectramax plus384 plate reader (Molecular Devices, Inc.) was used. All the solvents used were distilled prior to use. Column chromatography (CC) was performed with silica gel purchased from Thomas Baker Ltd. Preparative thin-layer chromatography (TLC) was carried out using TLC plates supplied by Merck Ltd. The M. tuberculosis H37Ra (ATCC 25 177) strain was obtained from MTCC, Chandigarh, India. Rifampicin (97.0 %), XTT sodium salt, and menadione were purchased from Sigma-Aldrich. 
Plant material
Extraction and isolation
Whole fruits obtained after acetone extraction were dried under airflow and pulverized. The pulverized fruit powder, 1.2 kg, was extracted with methanol by a cold maceration technique (3 L × 3 × 14 h) at room temperature. After solvent evaporation at a reduced pressure, a red-brown extract (31.0 g, 2.58 %, based on dry weight) was yielded. The methanol extract, 30 g, was separated by repeated CC on silica gel with different elution systems. The final purification of the compounds was achieved by preparative TLC. The detailed extraction and isolation of the compounds 1-13 as well as LC-ESI-MS, UV, IR, and NMR data of the compounds are available as Supporting Information.
Antimycobacterium bioassay using the XTT reduction menadione assay M. tuberculosis H37Ra cells (ATCC 25 177) were grown to the logarithmic phase (O. D. 59 5~1.0) in M. pheli medium. Compounds 1-13 were dissolved in dimethyl sulfoxide and stored in aliquots at − 20°C. A freshly prepared stock solution (1.25 mM) of XTT sodium salt in sterile 1 x PBS and 6 mM menadione in DMSO was used. Compounds were screened for their inhibitory effect on M. tuberculosis by following the XTT aeduction menadione assay (XRMA) protocol [23, 24] . Briefly, in all wells of the assay plate, 200 µM XTT were added and incubated at 37°C for 20 min. Menadione, 60 µM, was added and incubated at 37°C for 40 min. The optical density was recorded on a microplate reader at 470 nm (filter) against a blank prepared from cell-free wells. Absorbance given by the cells treated with the vehicle alone was taken as 100 % of cell growth. All the experiments were performed in triplicate and the quantitative values are expressed as the average ± standard deviation, and the IC 50 values were calculated from their dose-response curves (Figs. S5 and S6, Supporting Information). Compounds 11 and 12 exhibited promising inhibitory activity with IC 50 values of 0.89 ± 0.33 µg/mL (MIC 2.06 ± 0.41 µg/ mL) and 7.59 ± 0.42 µg/mL (MIC 11.56 ± 0.35 µg/mL), respectively, as compared to that of positive control rifampicin with an IC 50 value of 0.0019 ± 0.0003 µg/mL (MIC 0.02 ± 0.31 µg/mL).
Supporting information
1 H, 13 C, DEPT, and 2D correlations of compound 1, dose-response curves for compounds 11 and 12 against M. tuberculosis H37Ra, and the extraction, isolation, NMR, and other characterization data of compounds 1-13 are available as Supporting Information.
